Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review

OBJECTIVES: First, to investigate if switching biological disease-modifying antirheumatic drugs (bDMARDs) after the failure to prior bDMARD is efficacious in patients with axial spondyloarthritis (axSpA). Second, to evaluate the influence on this efficacy of (1) the reason to discontinue prior tumou...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:RMD Open
Main Authors: Navarro-Compán, Victoria, Plasencia-Rodríguez, Chamaida, de Miguel, Eugenio, Diaz del Campo, Petra, Balsa, Alejandro, Gratacós, Jordi
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2017
Assuntos:
Spondyloarthritis
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5640114/
https://ncbi.nlm.nih.gov/pubmed/29071119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000524
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares